Wilson Therapeutics AB is a privately-held biopharmaceutical company focused on developing novel treatments for Wilson Disease;a rare
Wilson Therapeutics has raised €36M across 1 funding round, most recently a round in Apr 2014. Based in Stockholm, Sweden; founded 2007; active in Healthtech. Data as of 7 Aug 2026.
Timing: dormant vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.
| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2014-04-01 | Other | €36M |
| — |
| View deal → |
